Logo image of CNTG

CENTOGENE NV (CNTG) Stock Fundamental Analysis

USA - NASDAQ:CNTG - NL0014040206 - Common Stock

0.325 USD
-0.02 (-6.23%)
Last: 8/7/2024, 8:06:53 PM
0.351 USD
+0.03 (+8%)
After Hours: 8/7/2024, 8:06:53 PM
Fundamental Rating

1

CNTG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. CNTG may be in some trouble as it scores bad on both profitability and health. CNTG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CNTG has reported negative net income.
In the past year CNTG has reported a negative cash flow from operations.
CNTG had negative earnings in each of the past 5 years.
In the past 5 years CNTG reported 4 times negative operating cash flow.
CNTG Yearly Net Income VS EBIT VS OCF VS FCFCNTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

CNTG's Return On Assets of -46.05% is on the low side compared to the rest of the industry. CNTG is outperformed by 85.34% of its industry peers.
Industry RankSector Rank
ROA -46.05%
ROE N/A
ROIC N/A
ROA(3y)-43.71%
ROA(5y)-32.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNTG Yearly ROA, ROE, ROICCNTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300 -400

1.3 Margins

The Gross Margin of CNTG (36.46%) is better than 63.79% of its industry peers.
CNTG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CNTG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.22%
GM growth 5Y-6.4%
CNTG Yearly Profit, Operating, Gross MarginsCNTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

CNTG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CNTG has more shares outstanding
Compared to 5 years ago, CNTG has more shares outstanding
Compared to 1 year ago, CNTG has a worse debt to assets ratio.
CNTG Yearly Shares OutstandingCNTG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
CNTG Yearly Total Debt VS Total AssetsCNTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

Based on the Altman-Z score of -1.03, we must say that CNTG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.03, CNTG is not doing good in the industry: 81.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC7.5%
CNTG Yearly LT Debt VS Equity VS FCFCNTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

CNTG has a Current Ratio of 1.02. This is a normal value and indicates that CNTG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CNTG (1.02) is worse than 68.10% of its industry peers.
CNTG has a Quick Ratio of 1.02. This is a bad value and indicates that CNTG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CNTG (0.96) is worse than 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.96
CNTG Yearly Current Assets VS Current LiabilitesCNTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CNTG have decreased by -6.92% in the last year.
The Revenue has been growing slightly by 2.25% in the past year.
The Revenue has been growing slightly by 3.70% on average over the past years.
EPS 1Y (TTM)-6.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.92%
Revenue 1Y (TTM)2.25%
Revenue growth 3Y8.07%
Revenue growth 5Y3.7%
Sales Q2Q%254.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y39.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNTG Yearly Revenue VS EstimatesCNTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CNTG Yearly EPS VS EstimatesCNTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CNTG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNTG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTG Price Earnings VS Forward Price EarningsCNTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNTG Per share dataCNTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNTG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTOGENE NV

NASDAQ:CNTG (8/7/2024, 8:06:53 PM)

After market: 0.351 +0.03 (+8%)

0.325

-0.02 (-6.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-17 2024-06-17
Earnings (Next)09-04 2024-09-04
Inst Owners0.09%
Inst Owner Change-99.99%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.97M
Revenue(TTM)48.54M
Net Income(TTM)-35.53M
Analysts82.86
Price Target1.53 (370.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.39
EYN/A
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)-1.36
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS1.94
BVpS-1.01
TBVpS-1.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.46%
FCFM N/A
ROA(3y)-43.71%
ROA(5y)-32.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.22%
GM growth 5Y-6.4%
F-Score2
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.95%
Cap/Sales 4.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.96
Altman-Z -1.03
F-Score2
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)25.62%
Cap/Depr(5y)60.29%
Cap/Sales(3y)7.53%
Cap/Sales(5y)16.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.92%
EPS Next Y39.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.25%
Revenue growth 3Y8.07%
Revenue growth 5Y3.7%
Sales Q2Q%254.74%
Revenue Next Year22.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.85%
OCF growth 3YN/A
OCF growth 5YN/A

CENTOGENE NV / CNTG FAQ

Can you provide the ChartMill fundamental rating for CENTOGENE NV?

ChartMill assigns a fundamental rating of 1 / 10 to CNTG.


What is the valuation status for CNTG stock?

ChartMill assigns a valuation rating of 0 / 10 to CENTOGENE NV (CNTG). This can be considered as Overvalued.


What is the profitability of CNTG stock?

CENTOGENE NV (CNTG) has a profitability rating of 1 / 10.


What is the expected EPS growth for CENTOGENE NV (CNTG) stock?

The Earnings per Share (EPS) of CENTOGENE NV (CNTG) is expected to grow by 39.38% in the next year.